Profilo
Joshua Rosenblat is the founder of 1907 Foundation.
He is currently working as an Assistant Professor at the University of Toronto, a Clinical & Technical Advisor at iGan Partners, and as the Chief Medical & Scientific Officer at Braxia Scientific Corp.
He completed his undergraduate degree at the University of Toronto and his doctorate at the University of Western Ontario.
Posizioni attive di Joshua Rosenblat
| Società | Posizione | Inizio |
|---|---|---|
| CHAMPIGNON BRANDS | Direttore Tecnico/Scientifico/R&S | 28/05/2021 |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Consulente / Consigliere | - |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
1907 Foundation | Fondatore | - |
Formazione di Joshua Rosenblat
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Finance |
Braxia Scientific Corp.
Braxia Scientific Corp. BiotechnologyHealth Technology Develops ketamine treatment and psychedelic medicine for mental health treatments | Health Technology |
1907 Foundation |
















